Generali Investments Cee, Investicni Spolecnost, A.S. Abbott Laboratories Transaction History
Generali Investments Cee, Investicni Spolecnost, A.S.
- $970 Billion
- Q4 2024
A detailed history of Generali Investments Cee, Investicni Spolecnost, A.S. transactions in Abbott Laboratories stock. As of the latest transaction made, Generali Investments Cee, Investicni Spolecnost, A.S. holds 28,250 shares of ABT stock, worth $3.62 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
28,250Holding current value
$3.62 Million% of portfolio
0.33%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,244Shares Held
1.31BCall Options Held
8.71MPut Options Held
8.03M-
Vanguard Group Inc Valley Forge, PA168MShares$21.5 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9.84 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$8.43 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.83 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $225B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...